← Back to Search

Not Applicable

MHNA-001 for Irritable Bowel Syndrome

N/A
Waitlist Available
Research Sponsored by Mahana Therapeutics
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

Study Summary

This trial will study the effects of a new treatment for IBS in 100 young adults, comparing it to usual care. The goal is to learn if it is effective and safe.

Eligible Conditions
  • Irritable Bowel Syndrome

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in IBS Severity Scoring System from Baseline to Week 12
Secondary outcome measures
Subject's Global Assessment of Relief at Week 12

Trial Design

1Treatment groups
Experimental Treatment
Group I: MHNA-001Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MHNA-001
2022
N/A
~200

Find a Location

Who is running the clinical trial?

Mahana TherapeuticsLead Sponsor
1 Previous Clinical Trials
100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To whom is eligibility for this clinical experiment open?

"This experiment is recruiting one hundred participants diagnosed with irritable bowel syndrome aged between 18 and 21. Applicants must satisfy the following criteria: have been affirmed to possess IBS through Rome IV questionnaire, show signs of mild, moderate or severe symptoms via an IBS-SSS score higher than 125 at screening stage, able to comprehend English language both written and spoken form; capable and enthusiastic in completing questionnaires related to Mahana™ IBS use as well as tracking associated conditions; unaltered medication dosage for over thirty days before entrance examination if any prescription drugs are taken by applicant; own a smartphone compatible with iOS 13 or later that has"

Answered by AI

Is this trial open for enrolment at the present moment?

"According to the clinical research posted on clinicaltrials.gov, this study is currently searching for participants. The trial was established on April 1st 2022 and has had a recent update as of August 22nd 2022."

Answered by AI

Are individuals of advanced age eligible for this clinical investigation?

"The requirements for this trial necessitate that participants be aged 18 to 21. Additionally, there are 379 trials available for minors under the age of 18 and 1007 studies open to seniors 65 or above."

Answered by AI

What is the aggregate of individuals enrolled in this investigation?

"Affirmative, the information present on clinicaltrials.gov states that this trial is actively recruiting patients. This research was first submitted on April 1st 2022 and has since been altered as of August 22nd 2022; 100 individuals are required to be enrolled from a single medical site."

Answered by AI

Who else is applying?

How old are they?
18 - 65
What site did they apply to?
Carolina Institute for Clinical Research
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
clinicaltrials.govStudy
MHNA-001 for Young Adults With IBS
2022. "MHNA-001 for Young Adults With IBS". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05333926.
~65 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top